Most flavonoids were classified as poorly soluble compounds with limited absorption windows in the upper small intestine.
Pharmaceuticals · 5 authors, 1 centre
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Most flavonoids were classified as poorly soluble compounds with limited absorption windows in the upper small intestine.
Most flavonoids were classified as poorly soluble with relatively high or low permeability (Class IIa/IIb) or low permeability (Class IV). The Bagley plot analysis indicated an absorption window in the upper small intestine with limited absorption time. A key gap identified was the paucity of experimental pKa, permeability, solubility, and recommended maximum daily dose data for many flavonoids. The authors concluded that enabling formulations are needed for Class IIa/IIb and IV flavonoids to improve bioavailability reproducibility.